Drugs Made In America Acquisition Corp. (DMAA)

Market Cap	339.59M
Revenue (ttm)	n/a
Net Income (ttm)	n/a
Shares Out	33.46M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	368
Open	10.15
Previous Close	10.04
Day's Range	10.15 - 10.15
52-Week Range	9.95 - 10.15
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About DMAA

Drugs Made In America Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses in the pharmaceutical industry. The company was incorporated in 2024 and is based in Fort Lauderdale, Florida.

• Industry: Shell Companies
• Sector: Financials
• IPO Date: Jan 28, 2025
• Country: United States
• Stock Exchange: NASDAQ
• Ticker Symbol: DMAA
• Website: https://dmaacorp.com